Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01866956
Other study ID # 1R43MH094092
Secondary ID 1R43MH094092
Status Completed
Phase
First received
Last updated
Start date September 1, 2016
Est. completion date April 30, 2018

Study information

Verified date January 2020
Source Center for Psychological Consultation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The KSADS-COMP will facilitate identification of comorbid psychiatric and substance use diagnoses frequently missed in clinical practice, and improve adolescent treatment outcomes. The self-administered version of the KSADS-COMP can also be used cost-effectively in schools and juvenile justice settings where there is a growing interest in early identification and referral of youth in need of mental health services. The KSADS-Bridge assessment tool with its RDoC neurocognitive tasks, when completed with the self- or clinician administered KSADS-COMP, will help to create cross-talk between the DSM and RDoC diagnostic perspectives, and begin to generate a database on the relationship between RDoC constructs and treatment outcomes across a range of diagnostic categories.


Description:

This Phase II SBIR grant is a follow-up to the Phase I SBIR grant "Computerized Screening for Comorbidity in Adolescents with Substance or Psychiatric Disorders." During Phase I, parent and adolescent self administered computerized versions of the psychiatric interview, the Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS), were developed to assess DSM-IVR diagnoses in adolescents. Since the funding of the Phase I grant, there have been two significant developments in the field: the American Psychiatric Association's release of the DSM-5 manual, and NIMH's launch of the Research Domain Criteria (RDoC) initiative that aims to create the necessary database to derive a new psychiatric nomenclature informed by neuroscience, genetics, and psychology. The primary goals of Phase II include: 1) Update the parent and adolescent self-administered computerized KSADS (KSADS-COMP) so it is compatible with DSM-5 criteria; 2) Develop software for a clinician-administered computerized KSADS (KSADS-COMP); 3) Create a KSADS- Bridge product that includes a battery of RDoC computerized neurocognitive tasks that can be completed with the self- or clinician-administered KSADS-COMP; and 4) Examine the criterion, convergent, and discriminant validity of the self-administered KSADS-COMP, and the relationship among DSM-5 diagnoses, dimensional measures of psychopathology, and performance on RDoC neurocognitive tasks. Ultimately the aim of this initiative is to create an instrument that, in addition to providing a reliable comprehensive assessment tool for psychiatric disorders in adolescents, can bridge DSM-5 and RDoC diagnostic perspectives. A sample of 400 adolescents and their parents will be recruited for this study: half will complete the self-administered KSADS-COMP; the other half will complete the clinician-administered KSADSCOMP. All 400 adolescents and their parents, in addition to completing one of the KSADS-COMP versions, will also complete a battery of dimensional symptom rating scales. A subset of 210 adolescents and their parents will then complete the other version of the KSADS-COMP to test diagnostic concordance between the self- and clinician-administered KSADS-COMP. To obtain reliable Kappa estimates, this subset will include 30 adolescents with no psychopathology and 30 adolescents that meet criteria for each of the following diagnoses: conduct disorder, major depression, bipolar; substance use disorders; post traumatic stress disorder; and attention deficit hyperactivity disorder. This subset of 210 adolescents will also be administered the RDoC battery of neurocognitive computerized tasks. The KSADS-COMP and KSADS-Bridge assessment tools will have multiple clinical and research applications. In addition to helping identify comorbidity in teens with substance or psychiatric disorders, it will help to create the cross-talk needed between the DSM and RDoC diagnostic perspectives, and will help to improve clinical care in the short- and long-run as the field aims to transition to a new psychiatric nomenclature.


Recruitment information / eligibility

Status Completed
Enrollment 223
Est. completion date April 30, 2018
Est. primary completion date April 1, 2018
Accepts healthy volunteers No
Gender All
Age group 11 Years to 17 Years
Eligibility Inclusion Criteria:

- adolescent between the ages of 11 and 17

Exclusion Criteria:

- Children will be excluded if they have a diagnosis of mental retardation (IQ < 70) or a severe psychosis that would impair the child's ability to participate.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Hugo W. Moser Research Institute at Kennedy Krieger Baltimore Maryland
United States University of Pittsburgh Pittsburgh Pennsylvania

Sponsors (5)

Lead Sponsor Collaborator
Center for Psychological Consultation Child Mind Institute, Hugo W. Moser Research Institute at Kennedy Krieger, Inc., National Institute of Mental Health (NIMH), University of Pittsburgh

Country where clinical trial is conducted

United States, 

References & Publications (1)

Townsend L, Kobak K, Kearney C, Milham M, Andreotti C, Escalera J, Alexander L, Gill MK, Birmaher B, Sylvester R, Rice D, Deep A, Kaufman J. Development of Three Web-Based Computerized Versions of the Kiddie Schedule for Affective Disorders and Schizophrenia Child Psychiatric Diagnostic Interview: Preliminary Validity Data. J Am Acad Child Adolesc Psychiatry. 2019 May 18. pii: S0890-8567(19)30332-6. doi: 10.1016/j.jaac.2019.05.009. [Epub ahead of print] — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Wilcoxon rank sum tests. compare scores on disorder-specific symptom rating scales between those with and without a specific diagnoses within 2 days of criterion measure
See also
  Status Clinical Trial Phase
Completed NCT03409991 - Testing the Efficacy of Opening Doors: A Career Guidance Intervention for Individuals With Psychiatric Disabilities N/A
Not yet recruiting NCT05316948 - Mental Health and Sexuality in Adolescents and Young Adults
Completed NCT04778163 - The Use of Humor With Young Adults in Psychiatric Care N/A
Not yet recruiting NCT06304363 - Braining - Evaluation of Acute Effects of Physical Exercise N/A
Recruiting NCT04096625 - Enhancement of a Psychotherapeutic Intervention Through Transcranial Direct Current Stimulation (tDCS) N/A
Not yet recruiting NCT05930353 - Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
Terminated NCT06012981 - Psychological Treatment in Psychiatric Inpatient Care N/A
Completed NCT04099173 - A Brief Mindfulness-Based Intervention for Suicidal Ideation N/A
Recruiting NCT04249960 - Sustain and Reinforce the Transition From Child to Adult Mental Health Care in Switzerland : A Monocentric Nested Cohort Randomized Controlled Trial: The SORT Study. N/A
Recruiting NCT05962424 - HNC: Human Neural Circuits Electrophysiology During Cognition Phase 1
Recruiting NCT06092866 - Digital Versus Telephone Symptom Assessment and Triage in Primary Care N/A
Recruiting NCT03678194 - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application N/A
Completed NCT03748355 - Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects N/A
Completed NCT05473962 - Mid-Term Follow-up Assessment After Exposure to Natural Disaster
Recruiting NCT05577585 - Ketamine and Stress in OCD N/A
Completed NCT05124158 - COVID-19 Severity and Psychiatric Morbidity
Recruiting NCT05560581 - Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy N/A
Completed NCT04618250 - Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) N/A
Not yet recruiting NCT06014164 - Qualitative Study About Psychedelics Using in Psychiatric Disorders
Active, not recruiting NCT05219357 - Ayurveda Based Intervention for Patients in Acute Psychiatric Crisis Situations N/A